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Abstract
Background: Currently, a suitable questionnaire in German language is not available to monitor the progression and
evaluate the severity of irritable bowel syndrome (IBS). Therefore, this study aimed to translate the Gastrointestinal
Symptom Rating Scale for Irritable Bowel Syndrome (GSRS-IBS) into German and to evaluate its psychometric qualities and
factorial structure.
Methods: This study is based on a total sample of 372 participants [62.6% female, mean age = 41 years (SD = 17 years)
]. 17.5% of the participants had a diagnosis of IBS, 19.9% were receiving treatment for chronic inflammatory bowel
disease, 12.1% of the participants were recruited from a psychosomatic clinic, and 50.5% belonged to a control group.
All participants completed the German version of GSRS-IBS (called Reizdarm-Fragebogen, RDF), as well as the Gießen
Subjective Complaints List (GBB-24) and the Hospital Anxiety and Depression Scale - German version (HADS-D).
Results: The internal consistency of the RDF total scale was at least satisfactory in all subsamples (Cronbach’s Alpha
between .77 and .92), and for all subscales (Cronbach’s Alpha between .79 and .91). The item difficulties (between .25
and .73) and the item-total correlations (between .48 and .83) were equally satisfactory. Principal axis analysis revealed a
four-factorial structure of the RDF items, which mainly resembled the structure of the English original. Convergent
validity was established based on substantial and significant correlations with the stomach-complaint scale of the GBB-
24 (r = .71; p < .01) and the anxiety (r = .42; p < .01) and depression scales (r = .43; p < .01) of the HADS-D.
Conclusion: The German version of the GSRS-IBS RDF proves to be an effective, reliable, and valid questionnaire for
the assessment of symptom severity in IBS, which can be used in clinical practice as well as in clinical studies.
Keywords: Irritable bowel syndrome, Questionnaire, Questionnaire design, Self-report, Colonic diseases
Background
Irritable bowel syndrome (IBS) is diagnosed on the basis
of recurrent abdominal pain related to defecation or
changes in stool frequency or form [1, 2]. The current
prevalence of IBS ranges from 2.5 to 25%, depending on
the diagnostic criteria used [3, 4]. For instance, the Man-
ning criteria are associated with considerably higher
prevalence rates when compared to the Rome I-III cri-
teria. The prevalence of IBS is higher in women than in
men. However, these gender differences decrease with in-
creasing age [5, 6].
Patients with IBS experience a great degree of stress as
a result of the condition. Several investigations with het-
erogeneous patient samples have illustrated that quality
of life is perceived as being significantly impaired [7–10].
Further, adolescents suffering from IBS report a lower
quality of life [11]. Moreover, IBS patients show consid-
erably reduced health-related quality of life on all scales
of the Short Form Health Survey (SF-36) [12] compared
to other patient groups such as those with heart insuffi-
ciency [13]. A recent cross-sectional study from Norway
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has shown that IBS is associated with poor outcomes,
particularly in the presence of health complaints, organic
diseases, and affective disorders [14].
Three validated scales are available to assess IBS sever-
ity, of which the IBS severity scoring system (IBS-SSS) is
most frequently used [15]. However, the IBS-SSS is an ex-
ternal assessment tool which has to be administered by
the treating physician.
Häuser [16] has produced a German translation of the
Rome III criteria for IBS that allows for a categorical decision
about the presence of IBS. However, none of these tools in-
clude a patient self-assessment which would provide valuable
additional information to the external assessment, particu-
larly with regard to the disruptions in quality of life fre-
quently occuring [9, 17]. The validated Gastrointestinal
Symptom Rating Scale for Irritable Bowel Syndrome (GSRS-
IBS) by Wiklund et al. [18] firstly represents such a diagnos-
tic tool, which is currently only available in the English
language.
The instrument was first introduced in 2003 with the
aim to establish a self-assessment tool specifically
adapted to IBS patients [18]. The GSRS-IBS is based on
the Gastrointestinal Symptom Rating Scale (GSRS-IBS,
[19]) developed for IBS patients and the Health-Related
Quality of Life Questionnaire (HRQL, [20]) which is dis-
ease independent.
Currently, there is no appropriate questionnaire available
in the German language (spoken by approximately 100
million people) to assess self-perceived symptom severity in
IBS. However, such an assessment tool would be useful in
the context of clinical practice as it would aid formation of
a diagnosis and the monitoring of the course of IBS and
additionally, for clinical studies.
Objectives
Therefore, the aim of this study was to develop a German
version of the GSRS-IBS (in the following called
Reizdarm-Fragebogen, RDF) and to carry out a cross-
cultural validation. For this purpose, the original question-
naire was translated into German and, in accordance with
Wiklund et al. [18], was subsequently validated in a sam-
ple of IBS patients. Moreover, control groups were in-
cluded to evaluate the specificity of the questionnaire.
Methods
The purpose of the following section is to provide a brief
overview of the translation and design process of the
German version of GSRS-IBS and to describe its validation
in a sample of different subgroups.
Design of the German instrument
GSRS-IBS
The English version GSRS-IBS includes 13 items, which
are rated on a seven-point scale ranging from "1 = no
discomfort at all" to "7 = very severe discomfort". All
items exclusively capture IBS constructs. The question-
naire was neither designed to produce ceiling effects nor
to assess redundant information. A factor-analytical
examination of all items in a validation cohort provided
the following five factors: pain, diarrhoea, satiety, consti-
pation, and bloating. Based on these findings identically
named subscales containing two to four items were de-
fined and demonstrated satisfactory internal consisten-
cies reflected in Cronbach’s Alpha (α) ranging from .74
to .85.
Translation
In order to ensure a high quality translation process, a
series of standards exists specifically for the cross-cultural
translation of psychological and medical questionnaires
[21]. The translation of the GSRS-IBS into German (RDF)
was conducted in accordance with these recommended
procedures. A preliminary version of the questionnaire
was subsequently tested in a clinical sample. Contrary to
the recommended standard specifications, no committee
of experts was consulted concerning the quality of the
questionnaire. Nonetheless, experienced gastroenterolo-
gists (including FL) confirmed its validity.
With regard to the specific process, two translators pos-
sessing the necessary knowledge of English and medical
expertise independently translated the original question-
naire into their native German language. Both translations
were then compared and the language was fine-tuned,
which resulted in the translators agreeing on one version
of the questionnaire. In order to assure the quality of the
translation, the new version was retranslated back to
English by two native English speakers who were not fa-
miliar with the original text. Except for some different
choice of wording, the original English text did not differ
from the retranslated version of the questionnaire, thus
confirming the accuracy of the initial translation of the
GSRS-IBS into German. Subsequently, the newly gener-
ated version of the questionnaire was given to a group of
patients in a psychosomatic rehabilitation clinic in Blies-
kastel (MediClin Biestal-Kliniken), who were asked to
check the comprehensibility of the items. None of these
patients reported problems with comprehension. There-
fore the German version was considered ready for imple-
mentation in the following validation study.
Study process
Sample recruitment
Validation cohorts Consecutive recruitment of the entire
sample of 372 participants took place from April 2011 until
June 2014. Out of these, 65 patients with a diagnosis of IBS
were recruited from the department of Internal Medicine II
at Saarland University Medical Centre in Homburg,
Germany, and from an Internal Medicine private practice
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in Neunkirchen, Germany. For quality control purposes,
the Rome III-criteria was used to validate the IBS diagnosis
in these patients, and only those with an appropriate diag-
nosis were included. A random selection of IBS patients
was not possible due to difficulties in ensuring a sufficient
sample size during recruitment. 45 patients with a psycho-
somatic disorder were recruited from the MediClin Bliestal
clinic in Blieskastel, Germany. Further, 74 patients with
chronic inflammatory bowel disease (IBD) who were
treated at Saarland University Medical Centre, Homburg,
Germany, took part. A control group of students and
orthopaedic patients with no gastroenterological conditions
was also included in the study. The students voluntarily
completed the questionnaires during an introductory
course of the elective course ‘Medical case history’ at Saar-
land University, and the orthopaedic patients were ques-
tioned in a radiology practice in Neustadt/Weinstraße,
Germany, whilst awaiting an MRI scan. The mean age of
the included subjects was M = 41 years (SD = 17 years) (for
sample characteristics see Table 1). The mean age would be
considerably higher, if the students were excluded from the
sample.
Study procedure and instruments
Study procedure In addition to the RDF, a German version
of the Hospital Anxiety and Depression Scale (HADS-D)
[22] as well as a short version of the Gießen Subjective
Complaints List (GBB-24) [23] were used to verify conver-
gent validity.
GBB-24 The GBB-24 assesses the psychosomatic causes
of physical complaints [23]. The 24-item short version
was given to subjects instead of the longer 57-item long
version [24]. GBB-24 assesses organ-specific, objective
and subjective symptoms. The following physical com-
plaints were documented: cardiac and gastric com-
plaints, pain in the limbs, and fatigue. The total score
represents the overall subjective complaints [25]. The
split-half-reliabilities were situated in a satisfactory range
between r = .75 (gastric discomfort) and r = .94 (general
complaints, total score).
HADS-D The HADS-D questionnaire contains 14 items
and assesses symptoms of anxiety and depression (7 items
per scale) based on somatic and physical complaints [22].
The HADS-D can therefore be applied as a screening tool
as well as to assess the severity of anxiety and depressive
symptoms. Both, the anxiety and the depression scale
showed a good internal consistency of α = .80.
Statistical analyses
Initially, according to Wiklund et al. [18] a total score of
the RDF as well as the individual sub-scores for the five
proposed subscales in the English version were calculated
for each subject by summing the total of the 13 items.
Moreover, sum scores were calculated for the identified
subscales in the German version following the outcome of
a subsequent factor analysis. Regarding both, the GBB-24
and the HADS-D, scoring was carried out according to
the respective manual instructions. A total score as well as
scores for the proposed subscales were calculated for the
GBB-24. Additionally, a total score for anxiety and depres-
sion symptoms was calculated for the HADS-D. In case of
missing data for a maximum of two of the 13 RDF items,
the missing values were replaced by the subject's mean
score. If three or more answers were missing, the subject
was excluded from all analyses. The same principle was
applied to the HADS-D and the GBB-24. However, in case
of the latter a subject was excluded from analyses if five
items or more were missing.
A new variable was created to compare presence versus
absence of IBS. Thereafter, a binary logistic regression was
calculated in order to verify if the IBS patients could be
distinguished from the other groups based on their RDF
results.
Internal consistencies (Cronbach’s Alpha, α, [26]) were
calculated for the entire questionnaire and for the sub-
scales identified in the German version of the question-
naire, to determine the reliability of the RDF.
Furthermore, the item difficulties and the item-total corre-
lations were evaluated in order to assess item quality. To
identify the factorial structure of the questionnaire, in
comparison to the English validation, a slightly different
procedure was employed: An exploratory principal axis
analysis was performed with an oblique (Direct oblimin,
Delta = 0) rotation. This analysis was chosen since ex-
ploratory factor analyses only consider item variance
which is shared by at least two items. This was deemed to
be more appropriate regarding measurement error [27].
Additionally, an oblique rotation appears to be more rea-
sonable concerning the nature of IBS symptoms with re-
spect to the chosen orthogonal rotation from Wiklund et
al. [18]. To assume that those who suffer from severe con-
stipation perceive the same amount of pain as those who
do not suffer from constipation is implausible, which is
Table 1 Age and gender distribution of the entire sample
subsample n age (years) women
(percent)M SD
IBS patients 65 49 12 58.5
Chronic IBD patients 74 45 15 58.1
Psychosomatic patients 45 54 8 68.9
Orthopaedic patients and students 188 33 16 64.4
Total 372 41 17 62.6
IBD inflammatory bowel disease, IBS irritable bowel syndrome
Schäfer et al. BMC Gastroenterology  (2017) 17:139 Page 3 of 8
why it seems appropriate to permit intercorrelations be-
tween factors.
The factor analyses were performed for the entire sam-
ple as well as separately for the subgroups (IBS, IBD, psy-
chosomatic patients and control groups). Consequently,
there is a factorial structure analysis for the entire sample
(n = 372) from which 83% did not have a diagnosis of IBS.
This can subsequently be compared to the factorial struc-
ture analysis in 65 patients with IBS. Moreover, this ana-
lysis in the IBS subsample can be compared with the IBS
sample that was recruited for the validation of the original
English version of the questionnaire. However, this com-
parison is limited due to the different types of factor ana-
lysis. Correlations with the GBB-24, its subscales and the
HADS-scores were calculated to illustrate the question-
naire's convergent construct validity.
Results
Descriptive statistics
A comparison of the mean RDF scores between the differ-
ent subgroups (see Table 2) revealed significant differences:
The group of IBS patients had a significantly higher total
score [t(111) = −12.27, p < .01], corresponding to more se-
vere symptoms related to IBS (see Fig. 1). Likewise, the stu-
dent [t(367) = 9.85, p < .01] and orthopaedic control groups
[t(367) = 2.65, p = .004] differed significantly from the mean
scores of all clinical samples. These considerable differences
could be demonstrated for all subscales of the question-
naire, irrespective of whether they were based on the Ger-
man or English factor structure. Binary logistic regression
analysis was used to differentiate IBS patients from the rest
of the cohort (non-IBS patients) using the RDF items.
Overall, 90.3% of IBS cases were correctly classified [χ2(13)
= 140.95, p < .01].
Assessment of item quality
Item quality
The item difficulties of the RDF ranged between p = .25
and p = .73 in the entire sample (see Table 3). As expected
they were slightly lower (p = .41 to p = .72) in the IBS sam-
ple and had a lower range. The majority of the items were
medium in difficulty with a few being very difficult or very
easy. Such a distribution appears to be reasonable for dif-
ferentiating IBS patients. The mean item-scale correlation
for the entire sample was r = .65. This corrected item-
scale correlation is satisfactory. However, it was consider-
ably lower for the IBS patients (mean r = .40). That is,
however, to be evaluated in context to the later described
diverging factorial structure.
Equally satisfactory are the results of the reliability ana-
lyses, with a Cronbach’s Alpha in the entire sample of α
= .92 for the RDF total scale (α = .77 in the IBS sample),
and Cronbach’s Alpha for the subscales of the German
version within an acceptable range from α = .84 to α = .93
(α = .72 to α = .92 in the IBS sample) [28].
Factor analyses
The suitability of conducting a factorial analysis on the data
derived from the entire sample was reflected in a KMO
value (Kaiser-Meyer-Olkin measure of sample adequacy) of
KMO= .88 and a significant Barlett test [χ2(78) = 3457.68,
p < .01]. The principal axis analysis with oblique rotation
(Oblimin direct, Delta = 0) provided a two-factorial result
for the overall sample according to Kaiser-Guttmann
(Table 4). The first factor indicated an eigenvalue of 6.69
while the second factor lagged noticeably behind with an
eigenvalue of 1.77. The KMO value of .68 for the IBS pa-
tients was not as strong, but nevertheless still appropriate
for conducting a factor-analytical evaluation. The lower
value might only reflect a significantly reduced sample size.
The Barlett test of sphericity was also significant [χ2(78) =
463.37, p < .01]. The principal axis analysis with an identical
rotation provided a four-factorial structure for the IBS sam-
ple according to Kaiser-Guttman. The first factor is charac-
terized principally by bloating-related sensations and the
passing of gas, whereas the second factor mainly summa-
rises symptoms of diarrhoea. The third factor is associated
with constipation while the fourth factor is related to the
urge to empty the bowel and the ensuing relief that the pa-
tients feel. In total, 64.5% of the item variance could be ex-
plained by these four extracted factors.
Intercorrelation of subscales
To determine the correlations between the various ques-
tionnaires, for RDF a total score with item 3 recoded was
calculated. This process takes the negative sign of the factor
scores into account. Subsequently, bivariate correlation
analyses were conducted between the subscale scores and
Table 2 Mean values and standard deviations (in brackets) of the RDF scales for the various samples
Subgroups Total (13 Items) Pain (2) Diarrhoea (4) Constipation (2) Satiety (2) Bloating (3)
IBS 50.85 (12.86) 8.03 (2.92) 14.74 (5.93) 5.74 (3.83) 7.89 (3.80) 14.45 (4.60)
Chronic IBD 31.90 (13.57) 4.59 (2.85) 11.62 (6.01) 3.30 (2.20) 4.41 (2.76) 7.98 (4.55)
Psycho-somatic 29.85 (15.90) 3.86 (2.35) 8.54 (5.17) 4.36 (3.24) 4.38 (3.13) 8.72 (5.68)
Control group 21.84 (10.59) 3.61 (2.43) 6.10 (3.26) 2.85 (1.86) 3.44 (2.06) 5.84 (3.90)
Total 29.88 (16.18) 4.61 (3.05) 9.00 (5.75) 3.63 (2.77) 4.52 (3.14) 8.12 (5.37)
IBD inflammatory bowel disease, IBS irritable bowel syndrome
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the total score of the RDF, both for the entire sample and
separately for patients with IBS (Table 5). This analysis re-
vealed that the first subscale, ‘bloating’ (items 3 and 4),
is the most independent. However, in IBS patients, a
substantial association with constipation-related com-
plaints was observed. Concerning the subscale 'diar-
rhoea' (items 6 and 7), significant correlations were
shown for 'constipation' however not for IBS patients),
'pain and feelings of tension'. Significant correlations
were identified between the subscale constipation
(items 5, 8, 11, 12, and 13), and all other subscales.
However, the correlations with 'diarrhoea' and 'pain and
feelings of tension' are not significant for IBS patients.
The subscales 'pain and feelings of tension' are consid-
erably associated with the scales 'diarrhoea' and 'consti-
pation' (but not for IBS patients). However, they were
not correlated with 'bloating' in both, the IBS and the
total sample. All subscales correlated significantly with
the RDF total score (with the exception of the ‘bloating’
subscale in the entire sample).
Fig. 1 Means of the GSRS-IBS/RDF total score for the different subgroups. Legend: The bars indicate the 95% confidence interval of the group
mean. GSRS-IBS Gastrointestinal Symptom Rating Scale for Irritable Bowel Syndrome; IBD (chronic) inflammatory bowel disease; IBS irritable bowel
syndrome; RDF Reizdarm-Fragebogen
Table 3 Item difficulties and item-total correlations for RDF in the entire sample and in the group of IBS patients
IBS patients Entire sample
Item difficulties Item-total correlations Item difficulties Item-total correlations
1. Stomach pain .62 .37 .36 .65
2. Relief through bowel movement .52 .50 .30 .75
3. Passing gas .71 .42 .41 .77
4. Stomach gas .72 .68 .40 .83
5. Constipation .41 .30 .25 .51
6. Diarrhoea or frequent bowel movement .48 .18 .30 .57
7. Liquid stool .41 .21 .73 .50
8. Hard stool .41 .30 .26 .48
9. Urge to empty bowel .59 .36 .37 .65
10. Feeling of complete emptying of the bowel .62 .56 .34 .75
11. Feeling of fullness after meals .55 .42 .31 .62
12. Prolonged feeling of fullness .58 .39 .33 .65
13. Bloated stomach .64 .51 .35 .77
IBS irritable bowel syndrome, RDF Reizdarm-Fragebogen
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Convergent validity
The correlations between the HADS-D and GBB-24
total scores and RDF scores reflect the convergent
validity for the latter (Table 6). All analysed samples
showed significant and similar correlations between
the responses on the RDF and those on the subscale
for stomach pain in the GBB-24. As expected, the
correlation was particulary strong in IBS patients (r =
.65, p < .01). The same applies to the correlation of
the GBB-total value that is associated with general
abdominal pain and the total scores of the RDF. Cor-
relations were significant for the entire sample (r
= .56, p < .01) as well as for the group of IBS patients
(r = .44, p < .01). Likewise, the correlations for the
subscales of the HADS-D depression and anxiety
were significant for the entire sample. It is, however,
apparent that the correlations of RDF score and
HADS scores are notably lower in the group of IBS
patients than in the total sample.
Discussion
The results suggest that the RDF as the German version of
the GSRS-IBS, can be used as a reliable and valid question-
naire to assess self-perceived severity and to monitor pro-
gress in IBS patients in German-speaking countries.
The present analyses establish the RDF as a reliable and
economical tool. This is evidenced by the sufficient psycho-
metric quality of the tests, its plausible, factorial structure
as well as its selective sensitivity for IBS symptoms. In line
with this, significant differences in the total RDF score were
reported for IBS patients in comparison to other clinical
and non-clinical samples. Its suitability is further reflected
by the convergent validity apparent in the correlations be-
tween the RDF and the GBB-24 and the HADS-D. The
present study further demonstrates that the German ver-
sion of the RDF is also suitable for subjective severity as-
sessment of IBS and that the same IBS construct is
consequently acquired in the English-speaking world as
well as in Germany [29].







Factor 4 Pain and feeling
of tension (2.52)
1. Stomach pain −.04 .06 .07 .49
2. Relief through bowel movement .10 −.13 −.13 .83
3. Passing gas −.93 .05 −.14 −.01
4. Stomach gas .87 .08 .18 .05
5. Constipation .06 −.39 .44 .12
6. Diarrhoea or frequent stool .11 .91 .02 .09
7. Liquid stool .05 .83 .10 .09
8. Hard stool .03 −.40 .45 .13
9. Urge to empty bowel −.05 .28 −.10 .62
10. Feeling of complete emptiness of the bowel .13 −.09 .14 .56
11. Feeling of fullness after meals −.12 .13 .92 −.01
12. Prolonged feeling of fullness .03 −.03 .85 −.09
13. Bloated stomach .23 .03 .49 .10
Note: Factor loadings > .40 in bold print
Table 5 Correlations and internal consistencies of the various dimensions in the entire sample (first correlation, n = 372) and the
subsample of IBS patients (second correlation, n = 65)
1 2 3 4 5
Bloating (1) .93/.90 .01/.05 .13*/.32* −.01/.07 .04/.25*
Diarrhoea (2) .89/.92 .37**/−.11 .58**/.31* .64**/.36**
Constipation (3) .85/.82 .63**/.22 .82**/.64**
Pain and feeling of tension (4) .84/.72 .91**/−.75**
RDF total (5) .92./.77
The diagonal contains internal consistencies of each subscale, first for the entire sample and second for the IBS subsample
IBS irritable bowel syndrome, RDF Reizdarm-Fragebogen
*p < .05
**p < .01
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However, it must be noted that the factorial structure of
the German version does not perfectly match the original
English version. The method of choice to prove the simi-
larity of the factorial structure would certainly have to be
a confirmatory factor analysis [30]. This method was de-
liberately not applied in the present study due to meth-
odological reasons. A different exploratory approach was
chosen that, on the one hand, seems to be more appropri-
ate for the data - with respect to the inter-factor correla-
tions and the considered variances - but, on the other
hand, distinctly limits the comparison of the findings with
the results from Wiklund et al. [18]. The employed factor-
ial analysis resulted in four instead of five factors and
raises concerns over whether the five-factorial structure
found in the English original and the associated interpret-
ation of the scales should be adjusted. It may be advisable
to initially focus on the value of the entire RDF and to
subsequently define the exact scale structure and compile
indications of its interpretation, only after a further valid-
ation sample.
Despite the scale structure that still needs to be investi-
gated, the RDF can certainly be recommended for its
application in a screening procedure. However, in order to
ensure a meaningful implementation in daily clinical prac-
tice or in general practitioner practices, it would be reason-
able to define cut-off-values. This would require a larger
sample of IBS patients, which would also be necessary to
determine the extent to which the questionnaire is suitable
to assess the subjective and additionally the objective de-
gree of IBS. A comparison with the currently used severity
scores in daily clinical practice would be particularly im-
portant. Such a comparison would also establish to what
extent the RDF can be meaningfully implemented to docu-
ment the (subjective) progression of IBS and if it should be
included in the standard therapy plan.
Limitations
On a critical note, only 65 patients with IBS were recruited
for this investigation, a small sample compared to the 234
IBS patients used in the validation of the original English
version. This relatively small sample size is especially
associated with limitations in the interpretation of the fac-
torial analytical results. Smaller samples (and thus samples
with a greater range restriction) are more likely to be asso-
ciated with a larger number of factors, which could present
an alternative explanation for the diverse factorial struc-
tures in the total cohort and in the group of IBS patients.
The fact that the IBS patients were less suitable for the fac-
tor analytic investigation is reflected in the significantly
lower KMO coefficients, even when compared to the entire
sample. Moreover, the control group comprising students
is a further limitation, as characteristics such as age, years
of education and socioeconomic status differed in the two
groups, thus limiting their comparability. However, the in-
clusion of orthopaedic patients should have reduced such
influences. Nevertheless, a replication and expansion of this
study with a larger patient cohort and a matched control
group would be desirable.
Additionally, not all aspects of the test quality could be
taken in consideration. For instance, findings regarding sta-
bility of the results in terms of retest-reliability are lacking.
The coherence of the HADS-D and the GBB-24 point to-
wards a persuasive convergent construct validity, while a
proof of a sufficient discriminant validity is indeed missing.
Likewise, it seems reasonable to examine the extent to which
the RDF scores correlate with other relevant variables within
IBS.
Conclusion
The German version of the GSRS-IBS RDF proves to be an
effective, reliable, and valid questionnaire for the assess-
ment of self-perceived symptom severity in IBS, which can
be used in clinical practice as well as in clinical studies.
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